|

Arthritis Clinical Trials in Atlanta, GA

27 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic ArthritisN/A<1 mi
Ketorolac in Upper Extremity Tendinopathy and ArthropathyPhase 4<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 3<1 mi
Preventing Injured Knees From osteoArthritis: Severity OutcomesPhase 2<1 mi
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)—<1 mi
A Long-term Extension (LTE) Study of Guselkumab in Pediatric ParticipantsPhase 3<1 mi
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisPhase 2<1 mi
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension—<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—<1 mi
Pectoralis Minor Release Versus Non-release in RSAN/A<1 mi
Primary Subtalar Arthrodesis for Calcaneal FracturesN/A<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1<1 mi
The Myelin Disorders Biorepository Project—<1 mi
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainPhase 36 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 36 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 36 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlarePhase 217 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Phase 217 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPhase 317 mi
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisPhase 217 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Phase 417 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 217 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsPhase 317 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPhase 226 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 327 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePhase 2/350 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 350 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.